Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:18

Leah M. Backhus

Written by
Leah Backhus MD MPH FACS trained at the University of Southern California and the University of California Los Angeles. She is Associate Professor of Cardiothoracic Surgery at Stanford University and has grant funding through the Veterans Affairs Administration and the NIH. Her research examines imaging surveillance following treatment for lung cancer. She holds several leadership roles within the STS, AATS, and WTS also serves as Chair of the Women and Lung Cancer Task Group of the National Lung Cancer Roundtable of the American Cancer Society and Chair of the ACGME Thoracic Residency Review Committee.
Sunday, 08 August 2021 11:18

Bruna Pellini

Written by
Dr. Bruna Pellini is an Assistant Member at the Department of Thoracic Oncology at Moffitt Cancer Center and Research Institute and an Assistant Professor at Morsani College of Medicine at University of South Florida. She received her medical degree from the Universidade Federal do Rio Grande do Sul, Brazil and completed her residency at University of Central Florida College of Medicine, where she was awarded the “Clinical Skills Award” in 2015, and was inducted into the prestigious Alpha Omega Alpha Honor Medical Society in 2016. Dr. Pellini completed her medical oncology fellowship at Washington University School of Medicine, St. Louis, where she worked at the laboratory of Aadel Chaudhuri, MD, PhD conducting research on circulating tumor DNA (ctDNA) for minimal residual disease (MRD) detection across different solid tumors. Dr. Pellini is an active member of the Lung Cancer Center of Excellence and the and Molecular Medicine Committees at Moffitt Cancer Center. She specializes in the care of patients diagnosed with lung cancer. Her research interest lies in the study of liquid biopsies as a biomarker to monitor treatment response and MRD, in the development of clinical trials incorporating ctDNA MRD to personalize treatment algorithms and trials with novel therapeutics targeting genomic alterations in non-small cell lung cancer.
Sunday, 08 August 2021 11:18

Zaid M. Abdelsattar

Written by
Sunday, 08 August 2021 11:18

Richard Freeman

Written by
Sunday, 08 August 2021 11:18

James Lubawski

Written by
Sunday, 08 August 2021 11:18

Wissam Raad

Written by
Sunday, 08 August 2021 11:18

Mark Jaradeh

Written by
Mark received his Bachelor of Science in neurobiology, physiology, and behavior from the University of California, Davis in 2016. Following a research internship at the UC Davis Cardiac Signaling Lab, Mark matriculated into the Loyola University Chicago Stritch School of Medicine Class of 2023. His research interests include minimally invasive thoracic surgery, non-small cell lung cancer, and inflammatory biomarkers.
Sunday, 08 August 2021 11:18

Chi-Fu Jeffrey Yang

Written by
Sunday, 08 August 2021 11:18

Michael Lanuti

Written by
Page 290 of 371